A lupus anticoagulant drawn on warfarin
A woman with a pulmonary embolism, on warfarin, has a lupus anticoagulant panel sent. The lab writes "no lupus anticoagulant detected, consistent with a deficiency of factors IX, XI, XII". Nobody is deficient. She is on warfarin. The PTT-based test cannot tell which intrinsic factor is low, so the report names all of them.
Concepts first
Why warfarin breaks the test
dRVVT dilute Russell viper venom time · PTT-LA partial thromboplastin time with a reagent built to be sensitive to the lupus anticoagulant · aCL anticardiolipin · anti-β2GPI anti-beta-2-glycoprotein I · ELISA enzyme-linked immunosorbent assay: it measures antibody binding, no clotting involved
The direct oral anticoagulants break the test the other way: they prolong the clock without emptying barrels and give false positives.ISTH (the thrombosis society) guidance: do not interpret LA on a direct oral anticoagulant; on warfarin, test only with INR under 1.5. Or use a venom test that skips the vitamin K factors: Taipan snake venom time with ecarin confirmation (Devreese 2020).
Decide in clinic
Write "lupus anticoagulant not interpretable on warfarin" in the chart. "Negative" will be copied forward for years.
Sources
Retrieved from PubMed, read on Oct 22, 2026.
- Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 2020. doi:10.1111/jth.15047
- Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 2023. doi:10.1002/art.42624
- Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018. doi:10.1182/blood-2018-04-848333
- Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv 2022. doi:10.1182/bloodadvances.2021005808
- Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the ISTH. J Thromb Haemost 2020. doi:10.1111/jth.14935
Low counts in cirrhosis: the spleen and the bottle, not the marrow
A man with alcohol-related cirrhosis is referred for "thrombocytopenia and anemia". White cells 2.5, hemoglobin 8, platelets 79 (counts in thousands). He bled in September. He is still drinking. Someone is thinking about a bone marrow.
Concepts first
Thrombocytopenia is present in about two thirds of cirrhotic patients and is a marker of portal pressure and a failing liver, not of marrow failure.Platelets under 150 in 64% of one cirrhosis series; leukopenia in only 5% (Bashour 2000). The count tracks spleen size and thrombopoietin; shunting the pressure alone restores little, transplantation restores it (Peck-Radosavljevic 2017).
Two ways a cirrhotic stomach bleeds
The beta-blocker is the treatment for both, and it needs a blood pressure to stand on.Nonselective beta-blockers are first line against recurrent gastropathy bleeding; TIPS when transfusions continue despite them (Baveno VII, de Franchis 2022; Kaplan 2024). Carvedilol is the preferred agent in compensated cirrhosis; start at the lowest tablet. Reduce or stop with systolic under 90 or acute kidney injury (de Franchis 2022).
Decide in clinic
2. Any NSAID (ibuprofen, naproxen, ketorolac): in cirrhosis it precipitates kidney injury and gastrointestinal bleeding; urgent care prescribes it for back pain without reading the chart. Acetaminophen is the painkiller, with a ceiling of 2 g a day in cirrhosis (NSAID avoidance: Biggins 2021).
The patient with a transfusion in September and no beta-blocker in October has an appointment with hepatology, not with hematology. Make it happen this month.
Sources
Retrieved from PubMed, read on Oct 22, 2026.
- Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017. doi:10.1111/liv.13317
- de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII: renewing consensus in portal hypertension. J Hepatol 2022. doi:10.1016/j.jhep.2021.12.022
- Kaplan DE, Ripoll C, Thiele M, et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024. doi:10.1097/HEP.0000000000000647
- Pérez-Ayuso RM, Piqué JM, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991. doi:10.1016/0140-6736(91)93125-S
- Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the AASLD. Hepatology 2021. doi:10.1002/hep.31884
- Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the AASLD. Hepatology 2021. doi:10.1002/hep.31646
- Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 2000. doi:10.1111/j.1572-0241.2000.02325.x
- Terrault N, Chen YC, Izumi N, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia (ADAPT-1 and ADAPT-2). Gastroenterology 2018. doi:10.1053/j.gastro.2018.05.025
- Ballard HS. The hematological complications of alcoholism. Alcohol Health Res World 1997;21:42. PMID 15706762.
Three iron traps from one afternoon
Three referrals for "anemia". Each chart had a number that was read wrong: a mean cell volume, a ferritin, and a hemoglobin electrophoresis.
Concepts first
Trap 1. "Anemia of chronic kidney disease, at goal"
A hemoglobin target is for after you know why it is low, not instead of knowing.Erythropoiesis-stimulating agents in kidney disease come after iron repletion and, outside dialysis, only with hemoglobin under 10; the ceiling is 11.5, because the trials that aimed at 13 or higher added stroke and thrombosis (KDIGO 2012). In non-dialysis kidney disease KDIGO accepts a 1 to 3 month oral iron trial; with a proton pump inhibitor, constipation or prior intolerance, go by vein.
Trap 2. Ferritin 695, saturation 5%
Ferritin rises with any inflammation; saturation does not lie upward.With inflammation, ferritin under 100 with saturation under 20% defines a deficiency that responds to intravenous iron (Camaschella 2015; Weiss 2019). In kidney disease the KDIGO thresholds in the figure apply. The hepcidin that raises ferritin also blocks the gut, which is why oral iron fails in these patients.
Trap 3. The electrophoresis read while the iron was low
The woman who stays microcytic after her ferritin is back to normal is the one who needs the electrophoresis.
Bonus. Heavy periods since the first one
Heavy periods since the first period is a bleeding history, not a gynecology history: send the von Willebrand panel before anyone blames the uterus.
Sources
Retrieved from PubMed, read on Oct 22, 2026.
- KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease, chapter 2: use of iron to treat anemia in CKD. Kidney Int Suppl 2012. doi:10.1038/kisup.2012.34
- KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease, chapter 3: use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl 2012. doi:10.1038/kisup.2012.35
- Camaschella C. Iron-deficiency anemia. N Engl J Med 2015. doi:10.1056/NEJMra1401038
- Camaschella C. Iron deficiency. Blood 2019. doi:10.1182/blood-2018-05-815944
- Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood 2019. doi:10.1182/blood-2018-06-856500
- Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol 2012. doi:10.1681/ASN.2011111078
- Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. Influence of iron deficiency anaemia on haemoglobin A2 levels: possible consequences for beta-thalassaemia screening. Scand J Clin Lab Invest 1999. doi:10.1080/00365519950186011
- Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004. doi:10.1111/j.1471-0528.2004.00176.x
- ACOG Committee Opinion No. 785: Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. Obstet Gynecol 2019. doi:10.1097/AOG.0000000000003411
- James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 2021. doi:10.1182/bloodadvances.2020003265
- Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv 2021. doi:10.1182/bloodadvances.2020003264